Hexasol Injection is a drug owned by NORBROOK LABORATORIES, LTD. It is protected by 1 US drug patent filed in 2017. All patents have expired. Details of Hexasol Injection’s patents and their expiration are given below.
| Drug Patent Number | Drug Patent Expiry | Status |
|---|---|---|
 | ||
| US6479473 | Active | |
Exclusivity Information
Hexasol Injection holds 1 exclusivity out of which 1 has expired. Details of Hexasol Injection's exclusivity codes and their expiration dates are given below.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| NCI | Nov 29, 2013 |
About Hexasol Injection
Hexasol Injection is a drug
owned by NORBROOK LABORATORIES, LTD.
Hexasol Injection uses
Flunixin Meglumine, Oxytetracycline as the active
ingredients.
Active Ingredient:
Hexasol Injection uses
Flunixin Meglumine,
Oxytetracycline
as the active ingredients.
Check out other Drugs and Companies using
Flunixin Meglumine, Oxytetracycline ingredient.